Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sorghum | 6 | 2022 | 7 | 1.470 |
Why?
|
| Spinal Fusion | 6 | 2025 | 153 | 1.420 |
Why?
|
| Frailty | 3 | 2023 | 24 | 1.180 |
Why?
|
| Spinal Cord Injuries | 6 | 2024 | 62 | 1.050 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2021 | 41 | 0.960 |
Why?
|
| Seeds | 3 | 2021 | 14 | 0.880 |
Why?
|
| Deep Brain Stimulation | 2 | 2022 | 9 | 0.880 |
Why?
|
| Edible Grain | 5 | 2022 | 9 | 0.860 |
Why?
|
| Autistic Disorder | 1 | 2024 | 12 | 0.850 |
Why?
|
| Autism Spectrum Disorder | 1 | 2024 | 25 | 0.830 |
Why?
|
| Plant Breeding | 2 | 2022 | 5 | 0.750 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2021 | 1 | 0.740 |
Why?
|
| Neurosurgical Procedures | 3 | 2022 | 223 | 0.710 |
Why?
|
| Thoracic Vertebrae | 2 | 2020 | 70 | 0.680 |
Why?
|
| Thoracotomy | 1 | 2020 | 17 | 0.670 |
Why?
|
| Chordoma | 1 | 2020 | 9 | 0.670 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 40 | 0.650 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 173 | 0.640 |
Why?
|
| Humans | 42 | 2025 | 28585 | 0.590 |
Why?
|
| Mental Recall | 2 | 2017 | 49 | 0.560 |
Why?
|
| Gamma Rhythm | 2 | 2014 | 3 | 0.550 |
Why?
|
| Adult | 21 | 2025 | 7922 | 0.510 |
Why?
|
| Tarlov Cysts | 1 | 2016 | 3 | 0.490 |
Why?
|
| Paraspinal Muscles | 1 | 2016 | 11 | 0.490 |
Why?
|
| Laminectomy | 1 | 2016 | 31 | 0.480 |
Why?
|
| Low Back Pain | 1 | 2016 | 29 | 0.480 |
Why?
|
| Microsurgery | 1 | 2016 | 46 | 0.480 |
Why?
|
| Theta Rhythm | 2 | 2014 | 2 | 0.470 |
Why?
|
| Oxylipins | 3 | 2019 | 7 | 0.460 |
Why?
|
| Cyclopentanes | 3 | 2019 | 17 | 0.450 |
Why?
|
| Female | 26 | 2025 | 15472 | 0.450 |
Why?
|
| Prospective Studies | 10 | 2025 | 1272 | 0.450 |
Why?
|
| Memory, Episodic | 1 | 2014 | 20 | 0.440 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 136 | 0.430 |
Why?
|
| Male | 24 | 2025 | 13772 | 0.420 |
Why?
|
| Electroencephalography | 4 | 2017 | 140 | 0.420 |
Why?
|
| Scoliosis | 2 | 2025 | 36 | 0.410 |
Why?
|
| Retrospective Studies | 11 | 2023 | 2612 | 0.410 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2025 | 40 | 0.400 |
Why?
|
| Cervical Vertebrae | 5 | 2024 | 118 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 834 | 0.390 |
Why?
|
| Middle Aged | 19 | 2025 | 7310 | 0.370 |
Why?
|
| Treatment Outcome | 8 | 2025 | 2402 | 0.370 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 114 | 0.350 |
Why?
|
| Language | 2 | 2024 | 65 | 0.320 |
Why?
|
| Common Data Elements | 2 | 2020 | 2 | 0.310 |
Why?
|
| Diskectomy | 2 | 2020 | 23 | 0.300 |
Why?
|
| Postoperative Complications | 5 | 2023 | 631 | 0.300 |
Why?
|
| Lumbar Vertebrae | 3 | 2023 | 129 | 0.270 |
Why?
|
| Brain Concussion | 2 | 2018 | 52 | 0.270 |
Why?
|
| Aged | 12 | 2025 | 5525 | 0.270 |
Why?
|
| Memory | 2 | 2017 | 76 | 0.260 |
Why?
|
| Cohort Studies | 4 | 2022 | 893 | 0.260 |
Why?
|
| Glasgow Coma Scale | 3 | 2021 | 21 | 0.250 |
Why?
|
| Verbal Learning | 2 | 2016 | 14 | 0.240 |
Why?
|
| Oligodendroglioma | 1 | 2025 | 13 | 0.240 |
Why?
|
| Length of Stay | 4 | 2020 | 240 | 0.240 |
Why?
|
| United States | 5 | 2022 | 2201 | 0.230 |
Why?
|
| Cognition Disorders | 2 | 2018 | 186 | 0.230 |
Why?
|
| Neurologic Examination | 1 | 2024 | 22 | 0.220 |
Why?
|
| Brain Mapping | 3 | 2017 | 207 | 0.220 |
Why?
|
| Reoperation | 2 | 2022 | 153 | 0.220 |
Why?
|
| Recovery of Function | 3 | 2022 | 122 | 0.220 |
Why?
|
| Criminal Law | 1 | 2024 | 6 | 0.210 |
Why?
|
| Movement | 1 | 2024 | 99 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 550 | 0.210 |
Why?
|
| Gene Expression Regulation, Plant | 3 | 2019 | 74 | 0.210 |
Why?
|
| Texas | 2 | 2021 | 138 | 0.200 |
Why?
|
| Plant Proteins | 3 | 2019 | 67 | 0.200 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2022 | 2 | 0.190 |
Why?
|
| Pilot Projects | 6 | 2022 | 458 | 0.190 |
Why?
|
| Incidence | 2 | 2021 | 568 | 0.190 |
Why?
|
| Lymphoma, B-Cell | 1 | 2022 | 19 | 0.190 |
Why?
|
| Treatment Failure | 1 | 2022 | 72 | 0.190 |
Why?
|
| Spondylolisthesis | 1 | 2022 | 12 | 0.190 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 77 | 0.190 |
Why?
|
| Parkinson Disease | 1 | 2022 | 47 | 0.180 |
Why?
|
| Cervical Cord | 2 | 2024 | 6 | 0.180 |
Why?
|
| Central Cord Syndrome | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2025 | 265 | 0.180 |
Why?
|
| Germination | 1 | 2021 | 8 | 0.180 |
Why?
|
| Patient Discharge | 2 | 2020 | 108 | 0.180 |
Why?
|
| Self Report | 1 | 2021 | 121 | 0.170 |
Why?
|
| Neurosurgery | 1 | 2022 | 76 | 0.170 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 5 | 0.170 |
Why?
|
| Hospital Charges | 1 | 2020 | 8 | 0.170 |
Why?
|
| Young Adult | 4 | 2024 | 2804 | 0.170 |
Why?
|
| Cold Temperature | 1 | 2021 | 35 | 0.170 |
Why?
|
| Malpractice | 1 | 2020 | 7 | 0.170 |
Why?
|
| Trauma Centers | 1 | 2021 | 123 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 478 | 0.170 |
Why?
|
| Virus Replication | 1 | 2021 | 66 | 0.170 |
Why?
|
| Lumbosacral Region | 2 | 2021 | 22 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 73 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 994 | 0.160 |
Why?
|
| Alleles | 2 | 2019 | 354 | 0.160 |
Why?
|
| RNA | 1 | 2021 | 111 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 7 | 0.160 |
Why?
|
| Plant Development | 1 | 2019 | 10 | 0.160 |
Why?
|
| Crops, Agricultural | 1 | 2019 | 19 | 0.160 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 16 | 0.160 |
Why?
|
| Patient Safety | 1 | 2020 | 38 | 0.160 |
Why?
|
| Software | 1 | 2021 | 126 | 0.160 |
Why?
|
| Neuropsychological Tests | 3 | 2018 | 247 | 0.160 |
Why?
|
| Fertility | 1 | 2019 | 60 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 36 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 272 | 0.150 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2018 | 1 | 0.150 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2018 | 3 | 0.150 |
Why?
|
| Risk Factors | 2 | 2021 | 2111 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2020 | 211 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 32 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2021 | 231 | 0.140 |
Why?
|
| Antifibrinolytic Agents | 1 | 2018 | 26 | 0.140 |
Why?
|
| Inflorescence | 1 | 2018 | 2 | 0.140 |
Why?
|
| Plant Growth Regulators | 1 | 2018 | 9 | 0.140 |
Why?
|
| Photic Stimulation | 2 | 2017 | 71 | 0.140 |
Why?
|
| Epilepsy | 2 | 2017 | 37 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 89 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 426 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2018 | 46 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 62 | 0.140 |
Why?
|
| Cheek | 1 | 2017 | 10 | 0.140 |
Why?
|
| Unconsciousness | 1 | 2017 | 4 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 20 | 0.140 |
Why?
|
| Laminoplasty | 1 | 2017 | 2 | 0.140 |
Why?
|
| Blood Alcohol Content | 1 | 2017 | 6 | 0.140 |
Why?
|
| Surgical Flaps | 1 | 2017 | 24 | 0.140 |
Why?
|
| Skull Base | 1 | 2017 | 35 | 0.140 |
Why?
|
| Gossypium | 1 | 2017 | 5 | 0.130 |
Why?
|
| Endoscopy | 1 | 2017 | 57 | 0.130 |
Why?
|
| Droughts | 1 | 2017 | 23 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2017 | 50 | 0.130 |
Why?
|
| Spondylosis | 1 | 2017 | 15 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2016 | 7 | 0.130 |
Why?
|
| Oryza | 1 | 2017 | 42 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 72 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 51 | 0.130 |
Why?
|
| Odontoid Process | 1 | 2016 | 13 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 121 | 0.120 |
Why?
|
| Registries | 3 | 2024 | 393 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2017 | 186 | 0.120 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2015 | 11 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2016 | 43 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 104 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2015 | 50 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 1026 | 0.120 |
Why?
|
| Auditory Cortex | 1 | 2014 | 2 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 32 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2014 | 64 | 0.110 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2014 | 3 | 0.110 |
Why?
|
| Seizures | 1 | 2014 | 49 | 0.100 |
Why?
|
| Aging | 2 | 2023 | 979 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 857 | 0.100 |
Why?
|
| Cognition | 1 | 2015 | 327 | 0.100 |
Why?
|
| Mutation | 3 | 2022 | 864 | 0.090 |
Why?
|
| Brain | 1 | 2017 | 753 | 0.090 |
Why?
|
| Electromyography | 2 | 2024 | 176 | 0.080 |
Why?
|
| Machine Learning | 2 | 2022 | 91 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 1600 | 0.080 |
Why?
|
| Gene Ontology | 2 | 2021 | 14 | 0.080 |
Why?
|
| Genome, Plant | 2 | 2022 | 27 | 0.080 |
Why?
|
| Decompression, Surgical | 2 | 2021 | 78 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 2045 | 0.080 |
Why?
|
| Spinal Cord Diseases | 2 | 2020 | 33 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 117 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 453 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 414 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 732 | 0.060 |
Why?
|
| Plants, Genetically Modified | 2 | 2017 | 25 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 115 | 0.060 |
Why?
|
| Phenotype | 2 | 2019 | 682 | 0.060 |
Why?
|
| Genotype | 2 | 2017 | 461 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 595 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2019 | 523 | 0.060 |
Why?
|
| Volition | 1 | 2024 | 6 | 0.060 |
Why?
|
| Epidural Space | 1 | 2024 | 11 | 0.060 |
Why?
|
| Upper Extremity | 1 | 2024 | 31 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2024 | 54 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2024 | 85 | 0.050 |
Why?
|
| Levodopa | 1 | 2022 | 11 | 0.050 |
Why?
|
| San Francisco | 1 | 2022 | 12 | 0.050 |
Why?
|
| Wakefulness | 1 | 2022 | 25 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2022 | 14 | 0.050 |
Why?
|
| Back Pain | 1 | 2022 | 21 | 0.050 |
Why?
|
| Decision Trees | 1 | 2022 | 8 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 148 | 0.050 |
Why?
|
| Medicaid | 1 | 2022 | 55 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 782 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2022 | 49 | 0.050 |
Why?
|
| Ilium | 1 | 2021 | 7 | 0.050 |
Why?
|
| Medicare | 1 | 2022 | 126 | 0.040 |
Why?
|
| Sacrum | 1 | 2021 | 25 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2023 | 622 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 251 | 0.040 |
Why?
|
| Bone Screws | 1 | 2021 | 43 | 0.040 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 2 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2021 | 3 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2021 | 13 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2021 | 14 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 21 | 0.040 |
Why?
|
| Genomics | 1 | 2022 | 123 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 32 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 74 | 0.040 |
Why?
|
| Internet | 1 | 2022 | 126 | 0.040 |
Why?
|
| Cricetinae | 1 | 2021 | 131 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 31 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 78 | 0.040 |
Why?
|
| Spinal Cord Compression | 1 | 2020 | 21 | 0.040 |
Why?
|
| Leukocytes | 1 | 2021 | 72 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 196 | 0.040 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2020 | 1 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2020 | 6 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 770 | 0.040 |
Why?
|
| Weight Loss | 1 | 2021 | 83 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2019 | 2 | 0.040 |
Why?
|
| alpha-Linolenic Acid | 1 | 2019 | 5 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 409 | 0.040 |
Why?
|
| Epitopes | 1 | 2021 | 185 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 50 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 214 | 0.040 |
Why?
|
| Neck Pain | 1 | 2019 | 7 | 0.040 |
Why?
|
| Radiculopathy | 1 | 2019 | 10 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 461 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 333 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2018 | 31 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 265 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 253 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 504 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 354 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 4 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 199 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 807 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 695 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 344 | 0.030 |
Why?
|
| Inpatients | 1 | 2018 | 60 | 0.030 |
Why?
|
| Glasgow Outcome Scale | 1 | 2017 | 4 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2017 | 12 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 664 | 0.030 |
Why?
|
| Longitudinal Ligaments | 1 | 2017 | 3 | 0.030 |
Why?
|
| Paralysis | 1 | 2017 | 11 | 0.030 |
Why?
|
| Quadriplegia | 1 | 2017 | 5 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 45 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 633 | 0.030 |
Why?
|
| Ossification, Heterotopic | 1 | 2017 | 7 | 0.030 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2017 | 10 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2017 | 14 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2017 | 22 | 0.030 |
Why?
|
| Cotton Fiber | 1 | 2017 | 3 | 0.030 |
Why?
|
| Agricultural Irrigation | 1 | 2017 | 3 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 23 | 0.030 |
Why?
|
| Thermotolerance | 1 | 2017 | 6 | 0.030 |
Why?
|
| Rain | 1 | 2017 | 20 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2017 | 22 | 0.030 |
Why?
|
| Phylogeny | 1 | 2019 | 489 | 0.030 |
Why?
|
| Photosynthesis | 1 | 2017 | 24 | 0.030 |
Why?
|
| Reaction Time | 1 | 2017 | 95 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 93 | 0.030 |
Why?
|
| Poaceae | 1 | 2016 | 26 | 0.030 |
Why?
|
| Valine | 1 | 2015 | 13 | 0.030 |
Why?
|
| Methionine | 1 | 2015 | 38 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 524 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2015 | 70 | 0.030 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2014 | 4 | 0.030 |
Why?
|
| Microelectrodes | 1 | 2014 | 19 | 0.030 |
Why?
|
| Beta Rhythm | 1 | 2014 | 1 | 0.030 |
Why?
|
| Delta Rhythm | 1 | 2014 | 1 | 0.030 |
Why?
|
| Alpha Rhythm | 1 | 2014 | 6 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2014 | 35 | 0.030 |
Why?
|
| Animals | 2 | 2021 | 10583 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 3165 | 0.030 |
Why?
|
| Nerve Net | 1 | 2014 | 111 | 0.020 |
Why?
|
| Epothilones | 1 | 2011 | 5 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 2011 | 5 | 0.020 |
Why?
|
| Carboplatin | 1 | 2011 | 112 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1455 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 4735 | 0.020 |
Why?
|
| Child | 1 | 2017 | 2271 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 325 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 1587 | 0.020 |
Why?
|